FCF Grants Awarded to Boston Children’s Hospital
Total grants: 2
- Development of a human-derived liver progenitor cell line with DNAJB1-PRKACA fusion gene and characterization of mitochondrial dynamics in fibrolamellar carcinoma — Principal investigator(s): Khashayar Vakili — 2022
- Development of a human-derived liver progenitor cell line with DNAJB1-PRKACA fusion gene — Principal investigator(s): Khashayar Vakili — 2019
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded to Boston Children’s Hospital.